Mitsuteru Kitade
Kashihara-shi, 6348521, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 60 publications
Corrigendum to "Loss of c-Met signaling sensitizes hepatocytes to lipotoxicity and induces cholestatic liver damage by aggravating oxidative stress" [Toxicology 361-362 (2016) 39-48].
Journal: Toxicology
Published: November 26, 2025
Endotoxin Activity Reflects an Increase in Body Temperature in Cirrhotic Patients With Ascites Undergoing Cell-free and Concentrated Ascites Reinfusion Therapy.
Journal: In vivo (Athens, Greece)
Published: March 07, 2022
Comparison of Ablation Area and Change in Functional Liver Reserve after Radiofrequency Ablation for Hepatocellular Carcinoma Using the arfa® and VIVA® Systems.
Journal: Journal of clinical medicine
Published: December 19, 2021
Bile Acid Sequestrant, Sevelamer Ameliorates Hepatic Fibrosis with Reduced Overload of Endogenous Lipopolysaccharide in Experimental Nonalcoholic Steatohepatitis.
Journal: Microorganisms
Published: May 19, 2020
Novel oral plasminogen activator inhibitor‑1 inhibitor TM5275 attenuates hepatic fibrosis under metabolic syndrome via suppression of activated hepatic stellate cells in rats.
Journal: Molecular medicine reports
Published: March 28, 2020
Combined Treatment with Sodium-Glucose Cotransporter-2 Inhibitor (Canagliflozin) and Dipeptidyl Peptidase-4 Inhibitor (Teneligliptin) Alleviates NASH Progression in A Non-Diabetic Rat Model of Steatohepatitis.
Journal: International journal of molecular sciences
Published: February 11, 2020
Gut dysbiosis associated with clinical prognosis of patients with primary biliary cholangitis.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: September 20, 2019
Exogenous Administration of Low-Dose Lipopolysaccharide Potentiates Liver Fibrosis in a Choline-Deficient l-Amino-Acid-Defined Diet-Induced Murine Steatohepatitis Model.
Journal: International journal of molecular sciences
Published: May 14, 2019
Acylcarnitine: Useful biomarker for early diagnosis of hepatocellular carcinoma in non-steatohepatitis patients.
Journal: World journal of gastrointestinal oncology
Published: March 21, 2019
ADAMTS13 and von Willebrand factor are useful biomarkers for sorafenib treatment efficiency in patients with hepatocellular carcinoma.
Journal: World journal of gastrointestinal oncology
Published: January 30, 2019
Identification of clinical risk factors for histological progression of primary biliary cholangitis.
Identification of clinical risk factors for histological progression of primary biliary cholangitis.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: January 15, 2019
Last Updated: 09/26/2026